JPS62501399A - 腫瘍転移に関連した伝播性を有するほ乳類遺伝子 - Google Patents

腫瘍転移に関連した伝播性を有するほ乳類遺伝子

Info

Publication number
JPS62501399A
JPS62501399A JP60505382A JP50538285A JPS62501399A JP S62501399 A JPS62501399 A JP S62501399A JP 60505382 A JP60505382 A JP 60505382A JP 50538285 A JP50538285 A JP 50538285A JP S62501399 A JPS62501399 A JP S62501399A
Authority
JP
Japan
Prior art keywords
cells
dna
metastasis
mammalian
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60505382A
Other languages
English (en)
Japanese (ja)
Inventor
バーンステイン，シエリー・シー
ウエインバーグ，ロバート・エイ
Original Assignee
ホワイトヘッド・インスティテュ−ト・フォ−・バイオメディカル・リサ−チ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ホワイトヘッド・インスティテュ−ト・フォ−・バイオメディカル・リサ−チ filed Critical ホワイトヘッド・インスティテュ−ト・フォ−・バイオメディカル・リサ−チ
Publication of JPS62501399A publication Critical patent/JPS62501399A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP60505382A 1984-11-30 1985-11-26 腫瘍転移に関連した伝播性を有するほ乳類遺伝子 Pending JPS62501399A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67662584A 1984-11-30 1984-11-30
US676625 1991-03-28

Publications (1)

Publication Number Publication Date
JPS62501399A true JPS62501399A (ja) 1987-06-11

Family

ID=24715276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60505382A Pending JPS62501399A (ja) 1984-11-30 1985-11-26 腫瘍転移に関連した伝播性を有するほ乳類遺伝子

Country Status (13)

Country Link
EP (1) EP0203970A1 (enrdf_load_stackoverflow)
JP (1) JPS62501399A (enrdf_load_stackoverflow)
AU (1) AU5197986A (enrdf_load_stackoverflow)
DK (1) DK359486A (enrdf_load_stackoverflow)
ES (1) ES8705043A1 (enrdf_load_stackoverflow)
FI (1) FI863095A0 (enrdf_load_stackoverflow)
GR (1) GR852864B (enrdf_load_stackoverflow)
HU (1) HUT41837A (enrdf_load_stackoverflow)
IL (1) IL77157A0 (enrdf_load_stackoverflow)
NO (1) NO863066L (enrdf_load_stackoverflow)
PT (1) PT81584B (enrdf_load_stackoverflow)
WO (1) WO1986003226A1 (enrdf_load_stackoverflow)
ZA (1) ZA859070B (enrdf_load_stackoverflow)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049662A (en) * 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
ES2164634T3 (es) * 1989-10-18 2002-03-01 Us Health Produccion y uso de proteina nm23-h2 humana y anticuerpos previstos a tal efecto.
US6825320B1 (en) 1995-03-29 2004-11-30 Millenium Pharmaceuticals, Inc. FOHY03 polypeptides
US6251597B1 (en) 1996-03-29 2001-06-26 Millennium Pharmaceuticals, Inc. Methods for detecting fohy030
US6794185B1 (en) 1995-03-29 2004-09-21 Millennium Pharmaceuticals, Inc. fohy030 nucleic acid molecules
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US5783182A (en) * 1996-01-30 1998-07-21 Baylor College Of Medicine Method for identifying metastatic sequences
DE69630142D1 (de) * 1995-11-16 2003-10-30 Baylor College Medicine Verfahren zur identifizierung metastatischer sequenzen
USRE38490E1 (en) 1995-11-16 2004-04-06 Baylor College Of Medicine Method for identifying metastatic sequences
WO1997025443A1 (en) * 1996-01-10 1997-07-17 The University Of Liverpool Metastasis inducing dna's
USRE38392E1 (en) 1996-01-30 2004-01-20 Baylor College Of Medicine Method for identifying metastatic sequences
US6312909B1 (en) 1996-03-29 2001-11-06 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis prevention and treatment of tumor progression
WO1999022773A2 (en) 1997-11-05 1999-05-14 Baylor College Of Medicine Sequences for targeting metastatic cells
EP1062340A2 (en) 1998-03-13 2000-12-27 The Baylor College of Medicine Compositions and methods for the treatment and prevention of metastatic disorders
US7462491B2 (en) 2002-01-31 2008-12-09 Baylor College Of Medicine Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin

Also Published As

Publication number Publication date
FI863095L (fi) 1986-07-29
FI863095A7 (fi) 1986-07-29
DK359486D0 (da) 1986-07-29
HUT41837A (en) 1987-05-28
ES8705043A1 (es) 1987-04-16
EP0203970A1 (en) 1986-12-10
AU5197986A (en) 1986-06-18
PT81584B (en) 1987-04-07
DK359486A (da) 1986-07-29
NO863066L (no) 1986-09-29
GR852864B (enrdf_load_stackoverflow) 1986-03-28
ZA859070B (en) 1986-07-30
IL77157A0 (en) 1986-04-29
ES549438A0 (es) 1987-04-16
NO863066D0 (no) 1986-07-29
FI863095A0 (fi) 1986-07-29
PT81584A (en) 1985-12-01
WO1986003226A1 (en) 1986-06-05

Similar Documents

Publication Publication Date Title
JPS62501399A (ja) 腫瘍転移に関連した伝播性を有するほ乳類遺伝子
AU2016201051B2 (en) Methods and compositions for diagnosis and treatment of cancer
CN102325548A (zh) 用于癌症的诊断和治疗的方法和组合物
US8771705B2 (en) Combination of protein vaccine and mesenchymal stem cells for treating cancer
CN111617249B (zh) hsa_circ_0007444在制备治疗卵巢癌的药物中的应用
CN103937872A (zh) Crm1在胃癌诊断与治疗中的应用
CN111996251A (zh) 一种恶性胶质瘤生物标志物的应用
CN105039342A (zh) 能抑制MAT2A基因表达的siRNA及其应用
CN103937871B (zh) Srrp35基因和表达产物在癌症诊断与治疗中的应用
CN109562121A (zh) 转移性癌症的诊断和治疗方法
CN118063584A (zh) 促肿瘤焦亡蛋白、靶向her2免疫促肿瘤焦亡蛋白及其编码基因与应用
CN111254130A (zh) Ddx24解旋酶点突变抑制肿瘤生长的方法及其应用
CN106701902A (zh) Foxr2基因和表达产物在肝癌诊断与治疗中的应用
CN116656583A (zh) 靶向肿瘤的幽门螺杆菌突变株及抗胃癌外膜囊泡组合物
CN113293208B (zh) 与肺癌增殖和转移相关的分子标志物及其应用
CN114807364A (zh) YRNA片段hY4F作为分子标志物在制备肺癌诊断试剂中的应用及抗肺癌药物
CN110893240B (zh) Nme2基因在抑制禽呼肠病毒复制中的应用
CN106701904B (zh) Acsl4基因和表达产物在胃癌诊断与治疗中的应用
CN116670172A (zh) 表达免疫检查点抑制剂的癌症特异性反式剪接核酶及其用途
CN101712960A (zh) Mac-2BP肿瘤抗原基因、蛋白、抗体及其用途
CN101363027B (zh) 携带短发夹rna的重组质粒的制备方法及用途
CN115141828B (zh) 干扰SQR基因的shRNA及其应用
CN118726488B (zh) 一种nexn基因高表达型骨肉瘤细胞系及其构建方法与应用
CN111454944B (zh) 一种分离的rna及其dna模板的合成方法
RØMER et al. Dissemination in athymic nude mice of lacZ transfected small cell lung cancer cells identified by X‐gal staining